NANO signs microreactor commercialisation MOU
The MOU will draw on Enveniam’s expertise to support NANO Nuclear’s reactor, fuel fabrication and transportation capabilities.
Serving the nuclear industry since 1956
The MOU will draw on Enveniam’s expertise to support NANO Nuclear’s reactor, fuel fabrication and transportation capabilities.
For the next generation of alpha therapy cancer treatments to become established, a steady supply of the key isotopes will be required. TerraPower Isotopes believes it has a long-term solution.
From the Archives: Atom, ahoy! The atom goes to sea
Beyond life extension
UK repository’s next chapter
SMRs: ready for market?